Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells

Anticancer Research

Volumn 33, Issue 5, 2013, Pages 1927-1934

  Takahashi, Yusuke ^a,b   Sawada, Genta ^a,b   Kurashige, Junji ^a   Matsumura, Tae ^a,b   Uchi, Ryutaro ^a   Ueo, Hiroki ^a   Ishibashi, Masahisa ^a   Takano, Yuki ^a   Akiyoshi, Sayuri ^a   Iwaya, Takeshi ^a   Eguchi, Hidetoshi ^a   Sudo, Tomoya ^a   Sugimachi, Keishi ^a   Yamamoto, Hirofumi ^b   Doki, Yuichiro ^b   Mori, Masaki ^b   Mimori, Koshi ^a  

^a KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; EMT; Tenascin C; TNC

Indexed keywords

MESSENGER RNA; TENASCIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SPECIFIC SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE RISK;

COLORECTAL CANCER; EMT; TENASCIN-C; TNC;

AGED; APOPTOSIS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; LASER CAPTURE MICRODISSECTION; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERITONEAL NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; STROMAL CELLS; TENASCIN; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84878177246     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pas J, Wyszko E, Rolle K, Rychlewski L, Nowak S, Zukiel R and Barciszewski J: Analysis of structure and function of tenascin-C. Int J Biochem Cell Biol 38: 1594-1602, 2006. (Pubitemid 43729294)
2. Jones FS and Jones PL: The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling. Dev Dynamics 218: 235-259, 2000. (Pubitemid 30349638)
3. Prieto AL, Edelman GM and Crossin KL: Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc Natl Acad Sci USA 90: 10154-10158, 1993. (Pubitemid 23328270)
4. Weber P, Ferber P, Fischer R, Winterhalter KH and Vaughan L: Binding of contactin/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin. FEBS Lett 389: 304-308, 1996. (Pubitemid 26251840)
5. Chung CY and Erickson HP: Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. Cell biol 126: 539-548, 1994.
6. Siri A, Knauper V, Veirana N, Caocci F, Murphy G and Zardi L: Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. Biol Chem 270: 8650-8654, 1995.
7. Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA and Virtanen I: Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: Biologic and pathologic implications. Hum Pathol 22: 636-643, 1991.
8. Erickson HP and Bourdon MA: Tenascin: An extracellular matrix protein prominent in specialized embryonic tissues and tumors. Ann Rev Cell Biology 5: 71-92, 1989. (Pubitemid 19286679)
9. Chiquet-Ehrismann R and Chiquet M: Tenascins: Regulation and putative functions during pathological stress. J Pathol 200: 488-499, 2003. (Pubitemid 36818249)
10. Orend G and Chiquet-Ehrismann R: Tenascin-C-induced signaling in cancer. Cancer Lett 244: 143-163, 2006.
11. Nagaharu K, Zhang X, Yoshida T, Katoh D, Hanamura N, Kozuka Y, Ogawa T, Shiraishi T and Imanaka-Yoshida K: Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am J Pathol 178: 754-763, 2011.
12. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M and Tamaki K: Tenascin-C up-regulation by transforming growth factor-beta in human dermal fibroblasts involves SMAD3, SP1, and ETS1. Oncogene 23: 1656-1667, 2004. (Pubitemid 38445158)
13. Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, Downey RJ, Manova-Todorova K, Brogi E and Massague J: Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat med 17: 867-874, 2011.
14. De Wever O, Nguyen QD, Van Hoorde L, Bracke M, Bruyneel E, Gespach C and Mareel M: Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 18: 1016-1018, 2004. (Pubitemid 39561510)
15. Riedl S, Kadmon M, Tandara A, Hinz U, Moller P and Faissner A: Tenascin-C tissue concentration in inflammatory and neoplastic diseases of the colon mucosa. Anticancer Res 17: 3165-3166, 1997. (Pubitemid 27434883)
16. Lundin M, Nordling S, Lundin J and Haglund C: Tenascin-C expression and its prognostic significance in colorectal cancer. Oncology 72: 403-409, 2007. (Pubitemid 351238156)
17. Sobin LH, Gospodarowicz MK, Wittekind C and International Union against Cancer: TNM classification of malignant tumors . New Jersey, Wiley-Blackwell, 2010.
18. Nishida K, Mine S, Utsunomiya T, Inoue H, Okamoto M, Udagawa H, Hanai T and Mori M: Global analysis of altered gene expressions during the process of esophageal squamous cell carcinogenesis in the rat: A study combined with a laser microdissection and a cDNA microarray. Cancer Res 65: 401-409, 2005.
19. Quackenbush J: Microarray data normalization and transformation. Nat Genetics 32 Suppl: 496-501, 2002.
20. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J and Vingron M: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genetics 29: 365-371, 2001. (Pubitemid 34326681)
21. Mizuno H, Kitada K, Nakai K and Sarai A: PrognoScan: A new database for meta-analysis of the prognostic value of genes. BMC Med Genomics 2: 18, 2009.
22. Staub E, Groene J, Heinze M, Mennerich D, Roepcke S, Klaman I, Hinzmann B, Castanos-Velez E, Pilarsky C, Mann B, Brümmendorf T, Weber B, Buhr HJ and Rosenthal A: An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types. J Mol Med 87: 633-644, 2009.
23. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A knowledgebased approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550, 2005. (Pubitemid 41528093)
24. Leung CT and Brugge JS: Outgrowth of single oncogeneexpressing cells from suppressive epithelial environments. Nature 482: 410-413, 2012.
25. Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, Céspedes MV, Sevillano M, Nadal C, Jung P, Zhang XH, Byrom D, Riera A, Rossell D, Mangues R, Massagué J, Sancho E and Batlle E: Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell 22: 571-584, 2012.